SARS: Severe Acute Respiratory Syndrome
Some close contacts, including healthcare workers, have developed similar illnesses. In response to these developments, CDC is initiating close watch for cases of SARS among recent travelers or their close contacts. As of March 21, 2003, the majority of patients identified as having SARS have been adults aged 25-70 years who were previously healthy. Few suspected cases of SARS have been reported among children aged less than 15 years.
Treatment have included several antibiotics to observationally treat known bacterial agents of atypical pneumonia. In many locations, therapy also has included antiviral agents such as oseltamivir or ribavirin. Steroids have also been administered orally or intravenously to patients in combination with ribavirin and other antimicrobials. At present, the most efficacious treatment regimen, if any, is unknown.
In the United States, clinicians who suspect cases of SARS are requested to report such cases to their state health departments. CDC requests that reports of suspected cases from state health departments, international airlines, cruise ships, or cargo carriers be directed to the SARS Investigative Team at the CDC Emergency Operations Center, telephone 770-488-7100. Outside the United States, clinicians who suspect cases of SARS are requested to report such cases to their local public health authorities. Additional information about SARS (e.g., infection control guidance and procedures for reporting suspected cases) is available at http://www.cdc.gov/ncidod/sars.
FastCounter by bCentral